Burden of disease of people with dementia in nursing homes measured by IPOS-Dem: a stepped-wedge cluster randomised controlled trial

Not Applicable

• Conditions: F03; Dementia in Alzheimer disease; Dementia, Alzheimer; F00; F01; F02; Vascular dementia; Dementia in other diseases classified elsewhere; Unspecified dementia

• Registration Number: DRKS00022339
• Lead Sponsor: Heds FR, School of Health Professions

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-05
• Study Completion: 2023-03-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 257

Inclusion Criteria

(1) Nursing Homes (NH): at least 8 People with dementia (PWD), use BESA or RAI for Routine Assessment; (2) PWD: Diagnosed with Alzheimers' disease or vascular dementia OR Symptoms of Dementia documented in NH Records.; (3) Nursing Staff: At least 18 years old, employed in respective NH for at least three months with a quota equivalent to at least 20% (= working one day per week), speak german; (4) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (2)

Exclusion Criteria

(1) PwD, who are hospitalised during the recruitment phase and therefore not physically in the nursing home at the time of study start; (2) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (1)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The improvement (= significant improvement of p<0.05) of Quality of life in People with Dementia (PwD) measured with the QUALIDEM outcome measure. <br>QUALIDEM is a proxy-rated, 18 item assessment instrument completed by frontline staff in nursing homes. The version used in this study assesses quality of life in people with moderate advanced dementia with regard to six dimensions and a total score. <br>The QUALIDEM will be measured every three months for 15 months. Longitudinal, total domain scores for People with Dementia will be calculated and illustrated to demonstrate the quality of life trajectory. The primary endpoint will be assessed between baseline, and month 1-15. <br>

Secondary Outcome Measures

Name	Time	Method
The secondary endpoint of this study is Burden of disease (BOD):<br>A reduction of burden of disease (BOD), measured with the total IPOS-Dem score (sum-score) in PwD compared to before and after the interventions.